» Articles » PMID: 37250921

T-cell Dysfunction in Natural Killer/T-cell Lymphoma

Overview
Journal Oncoimmunology
Date 2023 May 30
PMID 37250921
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer/T-cell lymphoma (NKTCL) is an incurable aggressive T-cell lymphoma closely correlated with Epstein‒Barr virus (EBV) infection. Chronic and consistent viral infection induces T-cell exhaustion. Herein, we describe T-cell dysfunction in NKTCL patients for the first time. Peripheral blood mononuclear cells (PBMCs) from age-matched healthy donors (HDs) and NKTCL patients were collected, and lymphocyte distributions, multiple surface inhibitory receptors (IRs), effector cytokine production and cell proliferation were determined by flow cytometry. PBMCs from HDs were cocultured with NKTCL cell lines to verify the clinical findings. IR expression was further assessed in NKTCL tumor biopsies using multiplex immunohistochemistry (mIHC). NKTCL patients have higher frequencies than HDs of inhibitory T regulatory cells (Tregs) and myeloid-derived suppressor cells (MDSCs). T-cell distribution also varies between NKTCL patients and HDs. T cells from NKTCL patients demonstrated higher expression levels of multiple IRs than HDs. Meanwhile, T-cell proliferation and interferon-γ production was significantly reduced in NKTCL patients. More importantly, the number of EBV-specific cytotoxic cells was lower in NTKCL patients, and these cells demonstrated upregulation of multiple IRs and secreted fewer effector cytokines. Interestingly, NKTCL cells caused normal PBMCs to acquire T-cell exhaustion phenotypes and induced generation of Tregs and MDSCs. In line with ex vivo finding, mIHC results showed that CD8+ T cells from NKTCL tumor biopsies expressed much higher level of IRs compared with reactive lymphoid hyperplasia individuals. The immune microenvironment of NKTCL patients exhibited T-cell dysfunction and accumulation of inhibitory cell components, which may contribute to impaired antitumor immunity.

Citing Articles

CPT1A mediates succinylation of LDHA at K318 site promoteing metabolic reprogramming in NK/T-cell lymphoma nasal type.

Tian H, Ge Y, Yu J, Chen X, Wang H, Cai X Cell Biol Toxicol. 2025; 41(1):42.

PMID: 39934546 PMC: 11814014. DOI: 10.1007/s10565-025-09994-6.


CD8 T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy.

Zhang B, Liu J, Mo Y, Zhang K, Huang B, Shang D Front Immunol. 2024; 15:1476904.

PMID: 39372416 PMC: 11452849. DOI: 10.3389/fimmu.2024.1476904.

References
1.
Fenwick C, Joo V, Jacquier P, Noto A, Banga R, Perreau M . T-cell exhaustion in HIV infection. Immunol Rev. 2019; 292(1):149-163. PMC: 7003858. DOI: 10.1111/imr.12823. View

2.
Thommen D, Schumacher T . T Cell Dysfunction in Cancer. Cancer Cell. 2018; 33(4):547-562. PMC: 7116508. DOI: 10.1016/j.ccell.2018.03.012. View

3.
Miller B, Sen D, Al Abosy R, Bi K, Virkud Y, LaFleur M . Subsets of exhausted CD8 T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019; 20(3):326-336. PMC: 6673650. DOI: 10.1038/s41590-019-0312-6. View

4.
Roussel M, Le K, Granier C, Gutierrez F, Foucher E, Le Gallou S . Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade. Blood Adv. 2021; 5(7):1816-1829. PMC: 8045516. DOI: 10.1182/bloodadvances.2020003080. View

5.
Bi X, Wang H, Zhang W, Wang J, Liu W, Xia Z . PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma. J Hematol Oncol. 2016; 9(1):109. PMC: 5064887. DOI: 10.1186/s13045-016-0341-7. View